|
Name:
|
Cann Group Limited
|
|
|
Business Description:
|
Cann Group Limited (ABN 25 603 949 739) is enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. The Company has built world-class research, cultivation and GMP manufacturing facilities in Melbourne, and a state-of-the-art large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. Cann Group also owns Satipharm and its patent-protected capsule technology.
|
|
Business Established:
|
30 January 2015
|
|
Board of Directors:
|
Allan McCallum
Doug Rathbone
Jenni Pilcher
John Sharman
|
|
CEO:
|
Peter Crock
|
|
Company Secretary:
|
Geraldine Farrell
|
|
Office:
|
4 Research Avenue,
Bundoora, Victoria 3083
Australia
|
|
Share Registry:
|
Link Market Services Limited
Tower 4,
727 Collins Street
Melbourne, Victoria, 3008
Ph: 1300 554 474
|
|
Auditors:
|
William Buck Audit (VIC) Pty Ltd
Level 20,
181 William Street
Melbourne, Victoria, 3000
Ph: 03 9824 8555
|
